|
시장보고서
상품코드
2035517
심혈관 의료기기 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Cardiovascular Devices Market Size, Share, and Growth Analysis, By Product, By Application (Coronary Artery Disease, Cardiac Arrhythmia), By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 심혈관 의료기기 시장 규모는 2024년에 600억 달러로 평가되었으며, 2025년 648억 달러에서 2033년까지 1,199억 4,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 8.0%로 성장할 것으로 전망됩니다.
세계 심혈관 기기 시장은 만성 심혈관질환의 유병률 증가를 주요 요인으로 견조한 성장세를 보이고 있습니다. 관상동맥 스텐트, 바이패스 요법 등 필수적인 심장 치료의 비용 효율성은 특히 신흥 시장에서 큰 영향을 미치며 보급을 촉진하고 있습니다. 이 시장을 이끄는 주요 요인으로는 급속한 기술 발전, 전 세계 심장 질환의 부담 증가, 최소침습 치료로의 전환 등이 있습니다. 심근경색, 뇌졸중과 같은 질환은 심장 관련 사망률에 크게 기여하고 있어 효과적인 관리 솔루션이 요구되고 있습니다. 또한, 심장 의료기기 제조 기술의 발전으로 그 적용 범위가 넓어지고 환자 치료 및 치료 결과가 향상되고 있습니다. 이러한 발전은 심혈관 의료기기가 전 세계적으로 심화되고 있는 심장 질환으로 인한 건강 문제를 해결하는 데 있어 매우 중요한 역할을 하고 있다는 것을 보여줍니다.
세계 순환기 의료기기 시장 성장요인
세계 심혈관 기기 시장은 전 세계 주요 사망원인인 심혈관질환(CVD)의 광범위한 확산에 의해 크게 견인되고 있습니다. 좌식 생활과 건강에 해로운 식습관의 증가, 그리고 고령화의 진행은 심부전, 고혈압 등 심각한 심혈관질환의 위험을 높이는 요인으로 작용하고 있습니다. 이에 따라 선진국과 개발도상국 모두에서 심박조율기, 제세동기, 스텐트 등 생명을 살리는 의료기기에 대한 필요성이 증가하고 있습니다. 병원과 클리닉이 환자 치료 결과를 개선하기 위해 첨단 기술을 도입하는 움직임에 힘입어 의료 시스템은 예방 의료와 질병 조기 발견에 점점 더 중점을 두고 있습니다. 한편, 다양한 정부 주도 이니셔티브와 비영리 단체는 고위험군에 대한 인식 개선 활동을 진행하고 있습니다.
세계 심혈관계 의료기기 시장의 억제요인
특히 개발도상국에서 심혈관 기기 도입을 가로막는 큰 장벽 중 하나는 이러한 첨단 기술에 따른 높은 비용입니다. 이식형 제세동기(ICD), 최첨단 영상 진단 기술 등 의료기기는 종종 고가이기 때문에 의료진이나 환자 모두에게 부담스러운 가격이 될 수 있습니다. 이러한 경제적 부담은 특정 지역의 불충분한 보험 적용 범위와 상환 체계로 인해 더욱 심각해져, 생명을 구해야 하는 환자들의 접근성을 제한하고 있습니다. 그 결과, 많은 사람들이 자신의 건강 상태를 크게 개선할 수 있는 필요한 의료기기를 구하지 못할 수 있습니다.
세계 순환기 의료기기 시장 동향
세계 순환기 의료기기 시장은 기술 발전과 환자의 자가 관리에 대한 관심이 높아지면서 재택 의료 솔루션으로 크게 변화하고 있습니다. 웨어러블 심전도 기기, 혈압계, 그리고 혁신적인 원격 환자 모니터링 시스템을 통해 개인이 집에서 자신의 심혈관 건강을 관리할 수 있도록 돕습니다. 이러한 추세는 실시간 데이터 수집을 가능하게 하고, 잦은 병원 방문을 최소화하면서 심부전 등 만성질환을 적극적으로 관리할 수 있게 해줍니다. 이러한 움직임은 접근성 향상과 의료비 절감을 통해 예방 의료의 새로운 시대를 열어 심혈관질환의 관리를 효율적이고 환자 중심으로 변화시키고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 심혈관 의료기기 시장 규모 : 제품별
세계의 심혈관 의료기기 시장 규모 : 용도별
세계의 심혈관 의료기기 시장 규모 : 최종사용자별
세계의 심혈관 의료기기 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.05.27Global Cardiovascular Devices Market size was valued at USD 60.0 Billion in 2024 and is poised to grow from USD 64.8 Billion in 2025 to USD 119.94 Billion by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).
The global cardiovascular devices market is experiencing robust growth, largely fueled by the rising prevalence of chronic cardiovascular diseases. The affordability of essential cardiac interventions, such as coronary stents and bypass therapies, is particularly impactful in emerging markets, driving wider adoption. Key factors propelling this market include rapid technological advancements, a growing global burden of heart diseases, and a shift toward less invasive treatment options. Conditions like myocardial infarction and stroke contribute significantly to heart-related mortality rates, necessitating effective management solutions. Additionally, advancements in manufacturing technologies for cardiac devices have broadened their applications, enhancing patient care and outcomes. These developments underscore the critical role cardiovascular devices play in addressing the escalating health challenges posed by heart diseases worldwide.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cardiovascular Devices Market Segments Analysis
Global Cardiovascular Devices Market is segmented by Product, Application, End-User and region. Based on Product, the market is segmented into Diagnostic & Monitoring Devices and Therapeutic & Surgical Devices. Based on Application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cardiovascular Devices Market
The Global Cardiovascular Devices market is significantly driven by the pervasive prevalence of cardiovascular diseases (CVDs), which rank as the foremost cause of mortality worldwide. The rising incidence of sedentary lifestyles, unhealthy dietary habits, and an increasingly aging population are contributing factors that elevate the risk of serious cardiovascular conditions, including heart failure and hypertension. Consequently, there is a growing necessity for life-saving medical devices such as pacemakers, defibrillators, and stents across both developed and developing regions. Healthcare systems are increasingly focusing on preventive care and early disease detection, fueled by hospitals and clinics adopting advanced technologies to enhance patient outcomes while various government initiatives and nonprofits work to raise awareness among high-risk groups.
Restraints in the Global Cardiovascular Devices Market
One of the significant obstacles hindering the adoption of cardiovascular devices, particularly in developing regions, is the high cost associated with these advanced technologies. Devices such as implantable cardioverter defibrillators (ICDs) and cutting-edge imaging techniques often come with substantial price tags that can be beyond the reach of healthcare providers and patients alike. This financial burden is further intensified by inadequate insurance coverage and reimbursement options in certain areas, which restricts access for patients in need of life-saving treatments. As a result, many individuals may be unable to obtain the necessary devices that could significantly improve their health outcomes.
Market Trends of the Global Cardiovascular Devices Market
The Global Cardiovascular Devices market is experiencing a significant shift towards home health solutions, driven by advancements in technology and a growing emphasis on patient self-management. Wearable ECG devices, blood pressure monitors, and innovative remote patient monitoring systems are empowering individuals to take control of their cardiovascular health from the comfort of their homes. This trend is facilitating real-time data collection, enabling proactive management of chronic conditions such as heart failure while minimizing the need for frequent hospital visits. By enhancing accessibility and reducing healthcare costs, this movement is ushering in a new era of preventative healthcare, making cardiovascular management both efficient and patient-centric.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & Buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global Cardiovascular Devices Market Size by Product & CAGR (2026-2033)
- Market Overview
- Diagnostic & Monitoring Devices
- ECG
- Implantable Cardiac Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- MRI
- PET Scanner
- Cardiovascular Ultrasound (2D, 3D/4D, Doppler)
- Cardiac Diagnostic Catheters
- Others
- Therapeutic & Surgical Devices
- Cardiac Resynchronization Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICDs)
- Pacemakers (Conventional, Leadless)
- Coronary Stents
- Catheters, Guidewires, Cannula
- Valves & Occlusion Devices
- Others
Global Cardiovascular Devices Market Size by Application & CAGR (2026-2033)
- Market Overview
- Coronary Artery Disease (CAD)
- Cardiac Arrhythmia
- Heart Failure
- Others
Global Cardiovascular Devices Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Specialty Clinics
- Others
Global Cardiovascular Devices Market Size & CAGR (2026-2033)
- North America (Product, Application, End-User)
- US
- Canada
- Europe (Product, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BIOTRONIK
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE HealthCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getinge
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- W. L. Gore & Associates
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Schiller
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
